University College London Featured PhD Programmes
University of Exeter Featured PhD Programmes
University of Leeds Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
The Hong Kong Polytechnic University Featured PhD Programmes
"elisa"×
10 miles

Cell Biology / Development (elisa) PhD Projects, Programs & Scholarships

We have 18 Cell Biology / Development (elisa) PhD Projects, Programs & Scholarships

  • "elisa" ×
  • Cell Biology / Development×
  • clear all
Order by 
Showing 1 to 10 of 18
  Development of novel macrophage high-throughput cell-based phenotypic assay for drug screening
  Research Group: Biomedical Research Group
  Dr G Pirianov, Prof S Cellek
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Investigating the anti-cancer effect of hop β -acid Lupulone and its synthetic derivatives on breast cancer cells
  Research Group: Biomedical Research Group
  Dr G Pirianov
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Regulation of the tissue degradation in osteoarthritis
  Research Group: Biomedical Research Group
  Dr J Bird, Dr P Coussons, Dr F Savage
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Regulation of trans-intestinal cholesterol efflux by pattern-recognition receptor signalling in enterocytes
  Research Group: Biomedical Research Group
  Dr C Erridge, Dr J Bird
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Antibody-drug conjugates (ADCs) for the treatment of solid tumours
  Dr S Karagiannis, Prof J Downward
Application Deadline: 29 November 2019

Funding Type

PhD Type

An Antibody-Drug Conjugate (ADC) comprises an antibody targeted toward a tumour cell surface antigen, coupled through a chemical linker to a highly-cytotoxic drug.
  MRC DiMeN Doctoral Training Partnership: Stopping bone metastasis in its tracks: Targeting glycan sugar groups to improve early diagnosis and prevent/inhibit the spread of prostate cancer to bone
  Dr J Munkley, Dr N Wang
Application Deadline: 6 January 2020

Funding Type

PhD Type

Prostate cancer is the most commonly diagnosed malignancy in men, claiming over 350,000 lives worldwide annually. More than 80% of men with advanced prostate cancer will develop painful and incurable bone metastasis.
  Cutting off the fuel supply to calcium pumps in pancreatic cancer: a novel therapeutic strategy
  Dr J Bruce, Prof K Williams, Dr A P Gilmore
Applications accepted all year round

Funding Type

PhD Type

Background and Rationale. Pancreatic ductal adenocarcinoma (PDAC) has the poorest survival and limited treatment options. Therefore, the search for novel therapeutic targets and drugs designed to selectively kill PDAC cells must remain a central research strategy.
  How do phosphodiesterases contribute to the pathophysiology of heart failure?
  Prof A Trafford, Dr K Dibb
Applications accepted all year round

Funding Type

PhD Type

Heart failure (HF) remains a major cause of death with worse 5-year survival than all forms of cancer combined. This project seeks to understand the mechanisms that underlie two important contributing factors to death in HF patients; i) contractile failure and, ii) the increased propensity for arrhythmias.
  The respiratory metagenome during exacerbations of asthma
  Prof N Papadopoulos, Prof D Robertson, Dr S Megremis
Applications accepted all year round

Funding Type

PhD Type

Asthma is an international pandemic, with 10% or more of the global population having experience asthma symptoms some time in life.
  Targeting steroid metabolism to block colorectal cancer proliferation
  Dr P Foster, Dr L Cox
Applications accepted all year round

Funding Type

PhD Type

Our group is a world leader in targeting specific aspects of steroid metabolism to block cancer growth. Our research has been instrumental in the successful pre-clinical and clinical development of various novel anti-cancer compounds.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.